news & events
SHALAKANY ACTS FOR GRIFOLS IN A STRATEGIC ALLIANCE WITH THE EGYPTIAN GOVERNMENT TO BOOST PLASMA-DERIVED MEDICINES SELF-SUFFICIENCY IN THE MIDDLE EAST AND AFRICA
Cairo, Egypt – Shalakany is delighted to announce that they have acted as local counsel for Grifols (one of the world’s leading producers of plasma-derived medicines) in a strategic alliance with the Egyptian government, through the National Service Projects Organization (“NSPO”), to boost plasma-derived medicines self-sufficiency in the Middle East and Africa.

On 24 November 2020, Grifols and NSPO signed a strategic agreement (Master Joint Venture Agreement) to further develop the Egyptian plasma-derivatives market and promote its self-sufficiency. Under this joint venture, owned by Grifols (49%) and NSPO (51%), the parties will join their industrial expertise and financial efforts for the development, construction and operation of 20 plasma collection centers throughout Egypt (with an initial capacity to collect 600,000 liters of plasma per year); manufacturing facilities, including a fractionation plant (with a capacity to fractionate up to 1 million liters of plasma per year) and a purification and fill-and-finish plant; a warehouse and an analysis laboratory. The plasma centers and manufacturing installations are expected to be operational at the end of 2025. The total expected capital expenditure for the project is estimated to be USD 300 million.

Aly El Shalakany, the Grifols relationship partner, said: “We are proud to have supported our client in this landmark national project which pairs Grifols’ unique expertise and Egypt’s distinctive capabilities. This project will achieve plasma self-sufficiency for Egypt and its citizens and establish Egypt as a regional and global supplier of plasma. I would like to express my congratulations to all of the stakeholders for reaching this successful and historic signing.”
more news
Shalakany Successfully Represents CIHC in Pachin Tender Offer
May 3, 2023
Shalakany Successfully Represents CIHC in Pachin Tender Offer

Shalakany is delighted to announce that, along with our dear friends at Al Ahly Pharos, we have successfully represented Paint and Chemical Industries (Pachin)’s majority shareholder, the Holding Company for Chemical Industries (CIHC), in the competitive bidding for the acquisition of Pachin’s shares. Dubai-based National Paints Holding (NPH) has acquired over 80% of Pachin for around EGP […]

read more
Shalakany – Legal 500 EMEA Rankings & Awards
April 13, 2023
Shalakany – Legal 500 EMEA Rankings & Awards

Shalakany is proud and delighted to share that it has been ranked as a Top Tier firm by Legal 500 in 6 different practice areas! The firm was awarded a Tier 1 ranking in Banking and Finance, Commercial, Corporate and M&A, Arbitration, Litigation, Energy, and Projects and Infrastructure. The Firm was also Recommended in 2 […]

read more